Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2022-11, Vol.140 (Supplement 1), p.6387-6389
Hauptverfasser:	Hayashi, Robert J., Hermiston, Michelle L., Teachey, David T., Devidas, Meenakshi, Wood, Brent L., Chen, Zhiguo, Annett, Robert D, Asselin, Barbara L, August, Keith J, Cho, Steve Y, Dunsmore, Kimberly P., Freedman, Jason L., Galardy, Paul J., Harker-Murray, Paul, Horton, Terzah M., Jaju, Alok I, Lam, Allison, Messinger, Yoav H., Miles, Rodney R., Okada, Maki, Patel, Samir I, Schafer, Eric S, Schechter-Finkelstein, Tal, Shimano, Kristin A., Singh, Neelam, Steele, Amii C., Sulis, Maria Luisa, Vargas, Sarah L, Winter, Stuart S., Wood, Charlotte, Zweidler-McKay, Patrick A, Loh, Mignon L., Hunger, Stephen P., Raetz, Elizabeth A., Bollard, Catherine M, Allen, Carl
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!